Met Life Investment Management, LLC Ardelyx, Inc. Transaction History

Met Life Investment Management, LLC

  • $18 Billion
  • Q4 2024

A detailed history of Met Life Investment Management, LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 135,156 shares of ARDX stock, worth $720,381. This represents 0.0% of its overall portfolio holdings.

Number of Shares
135,156
Previous 124,943 8.17%
Holding current value
$720,381
Previous $860,000 18.84%
% of portfolio
0.0%
Previous 0.01%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$4.49 - $6.85 $45,856 - $69,959
10,213 Added 8.17%
135,156 $698,000
Q3 2024

Nov 13, 2024
SELL
$5.28 - $7.57 $61,131 - $87,645
-11,578 Reduced 8.48%
124,943 $860,000
Q2 2024

Aug 13, 2024
BUY
$5.89 - $9.31 $118,265 - $186,935
20,079 Added 17.24%
136,521 $1.01 Million
Q1 2024

May 14, 2024
BUY
$6.05 - $9.74 $704,474 - $1.13 Million
116,442 New
116,442 $850,000
Q4 2023

Feb 14, 2024
BUY
$3.29 - $6.64 $29,827 - $60,198
9,066 Added 8.06%
121,552 $753,000
Q3 2023

May 09, 2024
BUY
$3.3 - $4.83 $371,203 - $543,307
112,486 New
112,486 $458,000
Q2 2023

Apr 29, 2024
BUY
$3.23 - $4.95 $363,329 - $556,805
112,486 New
112,486 $381,000
Q2 2023

Aug 10, 2023
BUY
$3.23 - $4.95 $363,329 - $556,805
112,486 New
112,486 $381,000
Q3 2021

Nov 15, 2021
SELL
$1.27 - $8.17 $41,396 - $266,309
-32,596 Closed
0 $0
Q2 2021

May 17, 2024
BUY
$6.55 - $8.98 $122,688 - $168,204
18,731 Added 135.1%
32,596 $247,000
Q2 2021

Jun 21, 2023
BUY
$6.55 - $8.98 $213,503 - $292,712
32,596 New
32,596 $247,000
Q2 2021

Mar 22, 2023
BUY
$6.55 - $8.98 $122,688 - $168,204
18,731 Added 135.1%
32,596 $247,000
Q2 2021

Aug 16, 2021
BUY
$6.55 - $8.98 $122,688 - $168,204
18,731 Added 135.1%
32,596 $247,000
Q1 2021

May 17, 2024
SELL
$6.1 - $7.69 $625,719 - $788,817
-102,577 Reduced 88.09%
13,865 $91,000
Q1 2021

Jun 26, 2023
BUY
$6.1 - $7.69 $84,576 - $106,621
13,865 New
13,865 $91.8 Million
Q1 2021

Mar 22, 2023
SELL
$6.1 - $7.69 $115,497 - $145,602
-18,934 Reduced 57.73%
13,865 $91,000
Q1 2021

May 14, 2021
SELL
$6.1 - $7.69 $115,497 - $145,602
-18,934 Reduced 57.73%
13,865 $92,000
Q4 2020

May 24, 2024
SELL
$5.05 - $7.1 $8,292 - $11,658
-1,642 Reduced 4.77%
32,799 $212,000
Q4 2020

Jun 22, 2023
BUY
$5.05 - $7.1 $165,634 - $232,872
32,799 New
32,799 $212,000
Q4 2020

Mar 22, 2023
SELL
$5.05 - $7.1 $8,292 - $11,658
-1,642 Reduced 4.77%
32,799 $212,000
Q4 2020

Feb 16, 2021
SELL
$5.05 - $7.1 $8,292 - $11,658
-1,642 Reduced 4.77%
32,799 $212,000
Q3 2020

May 24, 2024
SELL
$5.25 - $7.08 $13,471 - $18,167
-2,566 Reduced 6.93%
34,441 $181 Million
Q3 2020

Jun 26, 2023
BUY
$5.25 - $7.08 $180,815 - $243,842
34,441 New
34,441 $180,000
Q3 2020

Mar 22, 2023
SELL
$5.25 - $7.08 $13,471 - $18,167
-2,566 Reduced 6.93%
34,441 $180,000
Q3 2020

Nov 13, 2020
SELL
$5.25 - $7.08 $13,471 - $18,167
-2,566 Reduced 6.93%
34,441 $181,000
Q2 2020

May 24, 2024
SELL
$5.37 - $8.11 $426,565 - $644,217
-79,435 Reduced 68.22%
37,007 $256 Million
Q2 2020

Jun 26, 2023
BUY
$5.37 - $8.11 $198,727 - $300,126
37,007 New
37,007 $256,000
Q2 2020

Mar 22, 2023
BUY
$5.37 - $8.11 $62,694 - $94,684
11,675 Added 46.09%
37,007 $256,000
Q2 2020

Aug 14, 2020
BUY
$5.37 - $8.11 $62,694 - $94,684
11,675 Added 46.09%
37,007 $256,000
Q1 2020

Jul 12, 2023
BUY
$4.35 - $8.79 $110,194 - $222,668
25,332 New
25,332 $143,000
Q4 2019

Jul 12, 2023
BUY
$4.23 - $8.29 $107,154 - $210,002
25,332 New
25,332 $189,000
Q3 2019

Jul 12, 2023
BUY
$2.15 - $6.28 $54,463 - $159,084
25,332 New
25,332 $119,000
Q3 2019

Mar 22, 2023
BUY
$2.15 - $6.28 $54,463 - $159,084
25,332 New
25,332 $119,000
Q3 2019

Nov 14, 2019
BUY
$2.15 - $6.28 $54,463 - $159,084
25,332 New
25,332 $119,000

Others Institutions Holding ARDX

# of Institutions
233
Shares Held
150M
Call Options Held
1.54M
Put Options Held
3.08M
View Full List

About ARDELYX, INC.

ARDX Quotes by TradingView
  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $824M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email